BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230417
DTEND;VALUE=DATE:20230420
DTSTAMP:20260516T054601
CREATED:20221215T130847Z
LAST-MODIFIED:20221215T130847Z
UID:36096-1681689600-1681948799@www.pharmajournalist.com
SUMMARY:2nd LNP Formulation & Process Development Summit
DESCRIPTION:Turbocharging Your Next Gen LNP End-To-End Development to Deliver Curative Promises to Patients \nFollowing exciting industry updates from Verve Therapeutics’ GalNAc-LNP for PCSK9 for HFpEF treatment\, to Recode’s 5th element\, the 2nd LNP Formulation & Process Development Summit is your must-attend meeting as this nanoparticle continues to dominate the biopharmaceutical industry in 2023. \nNew for 2023\, we have curated 3 streams of content for 2nd iteration of the summit: \n\nIn depth discussions divulging IP and regulatory compliance for LNP drug products\nMaximized LNP flexibility and versatility for payloads beyond mRNA vaccines with other RNA\, DNA\, gene therapy and gene editing possibilities\nLipid Chemistry & Discovery Track: Novel lipid discovery and particle engineering to customize LNP composition for next generation delivery vehicle\nFormulation & Process Development Track: Optimize your LNP development techniques for enhanced manufacturability and product quality\, and overcome stability issues of LNP-nucleic acid drug products\nLNP CMC & Manufacturing Track: Elevating your process control\, CQAs framework for CMC\, GMP compliance for seamless scale-up\n\nThis summit will offer the most comprehensive content and exclusive data\, equipping you with end-to-end LNP development journey to exploit this lucrative non-viral delivery vehicle for various payloads to your destined cells and organs. \nIn collaboration with Intellia Therapeutics\, Pfizer\, Sanofi\, ReCode Therapeutics\, Akagera Medicines\, the 2nd LNP Formulation & Process Development Summit is committed to serving you with their lessons learned to supercharge your pipeline and deliver curative promises to patients. \nJoin us to stay at the forefront of science\, network with 350+ LNP Biology\, Chemistry\, Formulation & Process Development\, Tech Ops & Manufacturing experts to gain competitive advantage to exploit LNP potentials! \nTo know more visit: https://ter.li/ol6e27
URL:https://www.pharmajournalist.com/event/2nd-lnp-formulation-process-development-summit/
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR